AAAAAA

   
Results: 1-25 | 26-40
Results: 1-25/40

Authors: Westendorp, RGJ van Dunne, GM Kirkwood, TBL Helmerhorst, FM Huizinga, TWJ
Citation: Rgj. Westendorp et al., Optimizing human fertility and survival, NAT MED, 7(8), 2001, pp. 873-873

Authors: Bayley, JP de Rooij, H van den Elsen, PJ Huizinga, TWJ Verweij, CL
Citation: Jp. Bayley et al., Functional analysis of linker-scan mutants spanning the-376-308,-244, and-238 polymorphic sites of the TNF-alpha promoter, CYTOKINE, 14(6), 2001, pp. 316-323

Authors: Huizinga, TWJ Steens, SCA van Buchem, MA
Citation: Twj. Huizinga et al., Imaging modalities in central nervous system systemic lupus erythematosus, CURR OP RH, 13(5), 2001, pp. 383-388

Authors: Huizinga, TWJ Breedveld, FC
Citation: Twj. Huizinga et Fc. Breedveld, What will treatment of autoimmune diseases entail in 2010?, SPR SEM IMM, 23(1-2), 2001, pp. 187-192

Authors: van der Linden, MW Westendorp, RGJ Zidane, M Meheus, L Huizinga, TWJ
Citation: Mw. Van Der Linden et al., Autoantibodies within families of patients with systemic lupus erythematosus are not directed against the same nuclear antigens, J RHEUMATOL, 28(2), 2001, pp. 284-287

Authors: Lard, LR Huizinga, TWJ Hazes, JMW Vlieland, TPMV
Citation: Lr. Lard et al., Delayed referral of female patients with rheumatoid arthritis, J RHEUMATOL, 28(10), 2001, pp. 2190-2192

Authors: Bruijn, JA Verburgh, CA Huizinga, TWJ
Citation: Ja. Bruijn et al., Classifying lupus nephritis: A 32-year-old woman with systemic lupus erythematosus and nephritic syndrome, AM J KIDNEY, 37(3), 2001, pp. 653-657

Authors: van der Pol, WL Huizinga, TWJ Vidarsson, G van der Linden, MW Jansen, MD Keijsers, V de Straat, FGJLV Westerdaal, NAC de Winkel, JGJV Westendorp, RGJ
Citation: Wl. Van Der Pol et al., Relevance of Fc gamma receptor and interleukin-10 polymorphisms for meningococcal disease, J INFEC DIS, 184(12), 2001, pp. 1548-1555

Authors: Gibson, AW Edberg, JC Wu, JM Westendorp, RGJ Huizinga, TWJ Kimberly, RP
Citation: Aw. Gibson et al., Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus, J IMMUNOL, 166(6), 2001, pp. 3915-3922

Authors: van Ede, AE Laan, RFJM Rood, MJ Huizinga, TWJ van de Laar, MAFJ van Denderen, CJ Westgeest, TAA Romme, TC de Rooij, DJRAM Jacobs, MJM de Boo, TM van der Wilt, GJ Severens, JL Hartman, M Krabbe, PFM Dijkmans, BAC Breedveld, FC van de Putte, LBA
Citation: Ae. Van Ede et al., Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis - A forty-eight-week, multicenter, randomized, double-blind, placebo-controlled study, ARTH RHEUM, 44(7), 2001, pp. 1515-1524

Authors: Goossens, PH Havenga, MJE Pieterman, E Lemckert, AA Breedveld, FC Bout, A Huizinga, TWJ
Citation: Ph. Goossens et al., Infection efficiency of type 5 adenoviral vectors in synovial tissue can be enhanced with a type 16 fiber, ARTH RHEUM, 44(3), 2001, pp. 570-577

Authors: van Ede, AE Laan, RFJM Blom, HJ Huizinga, TWJ Haagsma, CJ Giesendorf, BAJ de Boo, TM van de Putte, LBA
Citation: Ae. Van Ede et al., The C677T mutation in the methylenetetrahydrofolate reductase gene - A genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients, ARTH RHEUM, 44(11), 2001, pp. 2525-2530

Authors: Goossens, PH Vogels, R Pieterman, E Havenga, MJE Bout, A Breedveld, FC Valerio, D Huizinga, TWJ
Citation: Ph. Goossens et al., The influence of synovial fluid on adenovirus-mediated gene transfer to the synovial tissue, ARTH RHEUM, 44(1), 2001, pp. 48-52

Authors: van der Linden, MW van Lopik, T Aarden, LA Westendorp, RGJ Huizinga, TWJ
Citation: Mw. Van Der Linden et al., Soluble CD95 concentrations are increased in patients with severe systemiclupus erythematosus, but not in their first degree relatives, ANN RHEUM D, 60(3), 2001, pp. 237-241

Authors: Rood, MJ Haverman, JF van Duinen, SG Breedveld, FC Verschuuren, JJGM Huizinga, TWJ
Citation: Mj. Rood et al., CNS involvement in systemic lupus erythematosus: a case with remarkable histopathological findings, ANN RHEUM D, 60(3), 2001, pp. 299-300

Authors: Polderman, MCA Huizinga, TWJ Le Cessie, S Pavel, S
Citation: Mca. Polderman et al., UVA-1 cold light treatment of SLE: a double blind, placebo controlled crossover trial, ANN RHEUM D, 60(2), 2001, pp. 112-115

Authors: Westendorp, RGJ Huizinga, TWJ
Citation: Rgj. Westendorp et Twj. Huizinga, Molecular analysis of gene-polymorphisms affecting the host response to infection, METH MOL M, 67, 2001, pp. 499-512

Authors: Goossens, PH Heemskerk, B van Tongeren, J Zwinderman, AH Vlieland, TPMV Huizinga, TWJ
Citation: Ph. Goossens et al., Reliability and sensitivity to change of various measures of hand functionin relation to treatment of synovitis of the metacarpophalangeal joint in rheumatoid arthritis, RHEUMATOLOG, 39(8), 2000, pp. 909-913

Authors: Huizinga, TWJ Keijsers, V Yanni, G Hall, M Ramage, W Lanchbury, J Pitzalis, C Drossaers-Bakker, WK Westendorp, RGJ Breedveld, FC Panayi, G Verweij, CL
Citation: Twj. Huizinga et al., Are differences in interleukin 10 production associated with joint damage?, RHEUMATOLOG, 39(11), 2000, pp. 1180-1188

Authors: van der Linden, MW Westendorp, RGJ Sturk, A Bergman, W Huizinga, TWJ
Citation: Mw. Van Der Linden et al., High interleukin-10 production in first-degree relatives of patients with generalized but not cutaneous lupus erythematosus, J INVES MED, 48(5), 2000, pp. 327-334

Authors: Huinink, DT Veltman, GAM Huizinga, TWJ Roelfsema, F Keizer, HJ
Citation: Dt. Huinink et al., Diabetes insipidus in metastatic cancer: Two case reports with review of the literature, ANN ONCOL, 11(7), 2000, pp. 891-895

Authors: Goossens, PH Schouten, GJ Heemskerk, B 't Hart, BA Bout, A Kluin, PM Breedveld, FC Valerio, D Huizinga, TWJ
Citation: Ph. Goossens et al., The effect of promoter strength in adenoviral vectors in hyperplastic synovium, CLIN EXP RH, 18(5), 2000, pp. 547-552

Authors: de Jong, BA Schrijver, HM Huizinga, TWJ Bollen, ELEM Polman, CH Uitdehaag, BMJ Kersbergen, MC Sturk, A Westendorp, RGJ
Citation: Ba. De Jong et al., Innate production of interleukin-10 and tumor necrosis factor affects the risk of multiple sclerosis, ANN NEUROL, 48(4), 2000, pp. 641-646

Authors: Rood, MJ Verschuuren, JJGM van Duinen, SG Maat-Schieman, ML Hegeman-Kleinn, IM van Buchem, MA Breedveld, FC Huizinga, TWJ
Citation: Mj. Rood et al., CNS involvement in primary Sjogren's syndrome: a case with a clue for the pathogenesis, J NEUROL, 247(1), 2000, pp. 63-64

Authors: Rood, MJ Borggreve, SE Huizinga, TWJ
Citation: Mj. Rood et al., Sensitivity to change of the MOS SF-36 quality of life assessment questionnaire in patients with systemic lupus erythematosus taking immunosuppressive therapy, J RHEUMATOL, 27(8), 2000, pp. 2057-2059
Risultati: 1-25 | 26-40